Axel Nierhaus

Axel Nierhaus is a Professor in the Department of Intensive Care Medicine at University Medical Center Hamburg-Eppendorf. His research focuses on Critical Care Medicine, particularly sepsis pathophysiology, COVID-19 therapeutics, cytokine storm syndrome, and hemoadsorption techniques. His work integrates clinical trials with mechanistic studies to advance critical care therapeutics.

Research interests span immunomodulation, biomarker development, extracorporeal blood purification, and precision medicine approaches in critical illness. Key areas include optimizing oxygen therapy in septic shock, steroid protocols, immunoglobulin applications, and hemoadsorption devices.

Recent publications demonstrate a strong focus on COVID-19 pathogenesis and management, with studies on vitamin C therapy, RAAS inhibitors, sex-specific outcomes, and cytokine storm characterization. Articles reveal consistent themes in inflammation modulation, organ support strategies, and long-term critical care outcomes.

Laboratory and clinical research activities concentrate on molecular pathways of inflammation, clinical trial design, and registry-based evidence generation for blood purification techniques.